The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - GlaxoSmithKline
ROAR: a phase 2, open-label study in patients (pts) with BRAF V600E–mutated rare cancers to investigate the efficacy and safety of dabrafenib (D) and trametinib (T) combination therapy.
 
Vivek Subbiah
Research Funding - Abbvie (Inst); Amgen (Inst); Bayer (Inst); Berg Pharma (Inst); Bioxell Pharma (Inst); D3 Oncology Solutions (Inst); Fujifilm (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Multivir (Inst); NanoCarrier (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Roche/Genentech (Inst)
 
Yung-Jue Bang
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Novartis (Inst)
 
Ulrik Niels Lassen
Research Funding - Roche (Inst)
 
Zev A. Wainberg
Consulting or Advisory Role - Amgen; Sirtex Medical; Taiho Pharmaceutical
Speakers' Bureau - Genentech
Research Funding - Biomarin (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Amgen; Genentech; Lilly
 
Jean-Charles Soria
Honoraria - AstraZeneca/MedImmune; Merus; MSD Oncology; Pfizer; Roche/Genentech; Symphony Evolution
 
Patrick Y. Wen
No Relationships to Disclose
 
Thorsten Zenz
Honoraria - Gilead Sciences; GlaxoSmithKline; Janssen
Consulting or Advisory Role - Gilead Sciences
Speakers' Bureau - Janssen; Mundipharma
Travel, Accommodations, Expenses - Mundipharma
 
Philippe Moreau
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Takeda
 
Paal Brunsvig
No Relationships to Disclose
 
Filippo G. De Braud
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck Serono; MSD; Novartis; SERVIER
 
Jacques De Greve
Consulting or Advisory Role - Novartis
Research Funding - Novartis
 
Maja J. De Jonge
No Relationships to Disclose
 
Ralf D. Hofheinz
Honoraria - Amgen; Bayer; Ipsen; Lilly; Merck; Roche
Consulting or Advisory Role - Amgen; Bayer; Ipsen; Lilly; Roche
Research Funding - Amgen; Bayer; Medac; Merck; Roche
 
Antoine Italiano
Consulting or Advisory Role - Merck Serono; MSD; PharmaMar
Research Funding - GlaxoSmithKline; MSD; Pfizer; Roche
 
Alexander Stein
Speakers' Bureau - Bayer; Celgene; Lilly; Roche; Sanofi
Research Funding - Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Roche
 
Wolfgang Willenbacher
No Relationships to Disclose
 
Jan H.M. Schellens
No Relationships to Disclose
 
Christoph Zielinski
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb
 
Fatima A. Rangwala
Employment - GlaxoSmithKline; Novartis
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - Genentech/Roche
 
Robert J. Kreitman
Research Funding - Genentech (Inst); GlaxoSmithKline (Inst)
Patents, Royalties, Other Intellectual Property - NIH/NCI (Inst)